Skip to main content
Top

25-09-2024 | Vitamin B12 Deficiency | Original Article

Elevated Serum Vitamin B12 Levels and Functional Vitamin B12 Deficiency among Patients with Myeloproliferative Neoplasms

Authors: Murugesan Harini, Kolar Vishwanath Vinod, Prashant S. Adole, Biswajit Dubashi

Published in: Indian Journal of Hematology and Blood Transfusion

Login to get access

Abstract

Background

Despite elevated serum vitamin B12 levels, functional (i.e., metabolically manifest) vitamin B12 deficiency has been reported in a significant proportion of MPN patients. This study aimed to assess the prevalence of functional vitamin B12 deficiency and elevated serum vitamin B12 levels among Indian MPN patients.

Methods

This cross-sectional study evaluated serum vitamin B12, homocysteine, methyl malonic acid (MMA) and holotranscobalamin levels among 176 MPN patients. Serum vitamin B12 levels between 150 and 950 pg/mL were considered normal. Functional vitamin B12 deficiency was diagnosed based on combination of elevated serum MMA (> 0.4 nmol/mL) and homocysteine (> 15 µmol/L) levels and low serum holotranscobalamin levels (< 25 pmol/L), irrespective of serum vitamin B12 levels and clinical manifestations of deficiency.

Results

Among patients enrolled (n = 176), 108 (61%) had chronic phase CML, 37 (21%) PV, 23 (13%) PMF and 8 (4%) ET. Nearly one-third were newly diagnosed to have MPNs and treatment naïve. Elevated serum vitamin B12 levels (> 950pg/mL) were seen in about a quarter (n = 45) of MPN patients. Half (n = 89) were detected to have functional vitamin B12 deficiency. No association was found between functional vitamin B12 deficiency and serum vitamin B12 levels and functional deficiency prevalence did not differ significantly between different types of MPNs and between newly diagnosed (treatment-naïve) and already treated MPNs.

Conclusion

About a quarter of MPN patients had elevated serum B12 levels and half had functional vitamin B12 deficiency. Functional deficiency was diagnosed independent of serum vitamin B12 levels. Hence, evaluation for functional deficiency should be carried out irrespective of serum vitamin B12 levels. Future studies should evaluate potential benefit of vitamin B12 replacement in MPN patients with functional vitamin B12 deficiency.
Literature
1.
go back to reference Andrès E, Serraj K, Zhu J, Vermorken AJ (2013) The pathophysiology of elevated vitamin B12 in clinical practice. QJM 106:505–515CrossRefPubMed Andrès E, Serraj K, Zhu J, Vermorken AJ (2013) The pathophysiology of elevated vitamin B12 in clinical practice. QJM 106:505–515CrossRefPubMed
2.
go back to reference Cinemre H, Serinkan Cinemre BF, Çekdemir D, Aydemir B, Tamer A, Yazar H (2015) Diagnosis of vitamin B12 deficiency in patients with myeloproliferative disorders. J Investig Med 63:636–640CrossRefPubMed Cinemre H, Serinkan Cinemre BF, Çekdemir D, Aydemir B, Tamer A, Yazar H (2015) Diagnosis of vitamin B12 deficiency in patients with myeloproliferative disorders. J Investig Med 63:636–640CrossRefPubMed
5.
go back to reference Gauchan D, Joshi N, Gill AS et al (2012) Does an elevated serum vitamin B(12) level mask actual vitamin B(12) deficiency in myeloproliferative disorders? Clin Lymphoma Myeloma Leuk 12:269–273CrossRefPubMed Gauchan D, Joshi N, Gill AS et al (2012) Does an elevated serum vitamin B(12) level mask actual vitamin B(12) deficiency in myeloproliferative disorders? Clin Lymphoma Myeloma Leuk 12:269–273CrossRefPubMed
6.
go back to reference Faurschou M, Nielsen OJ, Jensen MK, Hasselbalch HC (2000) High prevalence of hyperhomocysteinemia due to marginal deficiency of cobalamin or folate in chronic myeloproliferative disorders. Am J Hematol 65:136–140CrossRefPubMed Faurschou M, Nielsen OJ, Jensen MK, Hasselbalch HC (2000) High prevalence of hyperhomocysteinemia due to marginal deficiency of cobalamin or folate in chronic myeloproliferative disorders. Am J Hematol 65:136–140CrossRefPubMed
8.
go back to reference Hasan T, Arora R, Bansal AK, Bhattacharya R, Sharma GS, Singh LR (2019) Disturbed homocysteine metabolism is associated with cancer. Exp Mol Med 51:1–13CrossRefPubMed Hasan T, Arora R, Bansal AK, Bhattacharya R, Sharma GS, Singh LR (2019) Disturbed homocysteine metabolism is associated with cancer. Exp Mol Med 51:1–13CrossRefPubMed
9.
go back to reference Kim H, Deloughery EP, Algeciras-Schimnich A, Kumar N, Pruthi RK (2018) Measurement of vitamin B12 and serum methylmalonic acid levels: role of stepwise cascade testing in diagnosing vitamin b12 deficiency. Blood 132:4688–4688CrossRef Kim H, Deloughery EP, Algeciras-Schimnich A, Kumar N, Pruthi RK (2018) Measurement of vitamin B12 and serum methylmalonic acid levels: role of stepwise cascade testing in diagnosing vitamin b12 deficiency. Blood 132:4688–4688CrossRef
10.
go back to reference Valente E, Scott JM, Ueland PM, Cunningham C, Casey M, Molloy AM (2011) Diagnostic accuracy of holotranscobalamin, methylmalonic acid, serum cobalamin, and other indicators of tissue vitamin B12 status in the elderly. Clin Chem 57:856–863CrossRefPubMed Valente E, Scott JM, Ueland PM, Cunningham C, Casey M, Molloy AM (2011) Diagnostic accuracy of holotranscobalamin, methylmalonic acid, serum cobalamin, and other indicators of tissue vitamin B12 status in the elderly. Clin Chem 57:856–863CrossRefPubMed
13.
go back to reference Green R (2017) Vitamin B12 deficiency from the perspective of a practicing hematologist. Blood 129:2603–2611CrossRefPubMed Green R (2017) Vitamin B12 deficiency from the perspective of a practicing hematologist. Blood 129:2603–2611CrossRefPubMed
15.
go back to reference Gisslinger H, Rodeghiero F, Ruggeri M et al (1999) Homocysteine levels in polycythaemia vera and essential thrombocythaemia. Br J Haematol 105(2):551–555CrossRefPubMed Gisslinger H, Rodeghiero F, Ruggeri M et al (1999) Homocysteine levels in polycythaemia vera and essential thrombocythaemia. Br J Haematol 105(2):551–555CrossRefPubMed
Metadata
Title
Elevated Serum Vitamin B12 Levels and Functional Vitamin B12 Deficiency among Patients with Myeloproliferative Neoplasms
Authors
Murugesan Harini
Kolar Vishwanath Vinod
Prashant S. Adole
Biswajit Dubashi
Publication date
25-09-2024
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-024-01877-w

2024 ESMO Congress

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

  • Webinar | 01-10-2024 | 12:30 (CEST)

Live event concluded

In this webinar, Professor Martin Dreyling and an esteemed, international panel of CAR-T experts discuss the latest data on the safety, efficacy, and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL.

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by: Novartis Pharma AG

Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare
Get a reminder for the on-demand version